Last reviewed · How we verify
Colchicine 0.5mg
Colchicine 0.5mg is a Small molecule drug developed by Huashan Hospital. It is currently FDA-approved.
Colchicine 0.5mg is a small molecule inhibitor of the molecular target tubulin, classified as an inhibitor. It is being studied for various conditions, including gout, atrial fibrillation, and abdominal aortic aneurysm progression.
At a glance
| Generic name | Colchicine 0.5mg |
|---|---|
| Sponsor | Huashan Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk (PHASE3)
- Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease (PHASE4)
- Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome (PHASE2)
- PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis (PHASE3)
- Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage (PHASE3)
- Pilot Trial of Colchicine for Graft Failure in CABG (PHASE4)
- Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery (PHASE3)
- COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Colchicine 0.5mg CI brief — competitive landscape report
- Colchicine 0.5mg updates RSS · CI watch RSS
- Huashan Hospital portfolio CI
Frequently asked questions about Colchicine 0.5mg
What is Colchicine 0.5mg?
Who makes Colchicine 0.5mg?
What development phase is Colchicine 0.5mg in?
Related
- Manufacturer: Huashan Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing